Zum Hauptinhalt springen
Kapitel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

World Medical Association Declaration of Helsinki

Veröffentlichen auch Sie bei De Gruyter Brill
Part 1
Ein Kapitel aus dem Buch Part 1
© 2020 Walter de Gruyter GmbH, Berlin/Munich/Boston

© 2020 Walter de Gruyter GmbH, Berlin/Munich/Boston

Kapitel in diesem Buch

  1. Frontmatter I
  2. Editors V
  3. List of first-mentioned contributors V
  4. Preface IX
  5. Contents XI
  6. Research methods and the discovery of insulin 1
  7. The discovery of the oral treatment of diabetes mellitus with sulphonylureas 11
  8. Epidemiological research methodologies for the study of the aetiology of IDDM 21
  9. Epidemiological research methodologies for NIDDM 37
  10. Methodological concerns in diagnosing the prediabetic state 57
  11. Genetic patterns of IDDM related to environmental factors 73
  12. Immune mechanisms of beta cell destruction in the prediabetic phase of IDDM patients: research methodologies identifying susceptible individuals 89
  13. Interventions attempting at preventing or ameliorating the development of type 1 diabetes 105
  14. Assays for measuring proinsulin, insulin, and related peptides 119
  15. Assessment of insulin production and secretion dynamics in health and disease, including diabetes 133
  16. Methodologies in characterization and classification of prediabetic states to non-insulin-dependent diabetes mellitus (NIDDM) 147
  17. Research methodologies in hypoglycaemia: counterregulation phenomena and nerve/brain dysfunction 171
  18. Methods in evaluating lipoprotein and triglyceride metabolism in diabetes 191
  19. Research methodologies in the evaluation of intestinal glucose absorption and the concept of glycaemic index 205
  20. Evaluation of cardiac autonomic neuropathy by heart rate variability 219
  21. Methodologies in sodium-lithium countertransport as related to other cation transport systems in diabetes 241
  22. Methods in the assessment of transcapillary escape rate of plasma proteins 255
  23. Measurement of advanced glycosylation endproducts 273
  24. Research methodologies in the evaluation of home glucose monitoring 287
  25. Measurements of glycated haemoglobin and other circulating glycated proteins 299
  26. Research methodologies in evaluating patient education in diabetes — to reflect on the goals of patient education 319
  27. Research methodologies in diabetic retinopathy 333
  28. Methodologies to assess renal function in diabetes mellitus 359
  29. Conducting clinical trials in diabetic eye disease 387
  30. Economic analysis in diabetes 405
  31. Research methodologies in connective tissue changes and diabetic skin disease 417
  32. Measurement of extracellular fixed anionically charged molecules 433
  33. Methods in measuring glucose transporters and insulin receptors in target cells from humans 449
  34. World Medical Association Declaration of Helsinki 463
  35. Subject index 467
Heruntergeladen am 23.4.2026 von https://www.degruyterbrill.com/document/doi/10.1515/9783110878080-032/html
Button zum nach oben scrollen